Turck, DominiqueCastenmiller, JacquelineDe Henauw, StefaanHirsch-Ernst, Karen IldicoKearney, JohnKnutsen, Helle KatrineMaciuk, AlexandreMangelsdorf, IngeMcArdle, Harry JNaska, AndronikiPelaez, CarmenPentieva, KristinaThies, FrankTsabouri, SophiaVinceti, MarcoBresson, Jean-LouisSiani, AlfonsoEFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)2021-05-292021-05-292020-10-22Turck, D, Castenmiller, J, De Henauw, S, Hirsch-Ernst, K I, Kearney, J, Knutsen, H K, Maciuk, A, Mangelsdorf, I, McArdle, H J, Naska, A, Pelaez, C, Pentieva, K, Thies, F, Tsabouri, S, Vinceti, M, Bresson, J-L, Siani, A & EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2020, 'Anxiofit-1 and reduction of subthreshold and mild anxiety : evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006', EFSA Journal, vol. 18, no. 10, e06264. https://doi.org/10.2903/j.efsa.2020.62641831-4732PubMedCentral: PMC7579687ORCID: /0000-0002-9275-9713/work/99981906https://hdl.handle.net/2164/16574Acknowledgements: EFSA wishes to acknowledge the contribution of WG on Claims: Jean‐Louis Bresson, Stefaan de Henauw, Alfonso Siani and Frank Thies to this opinion. Requestor: Competent Authority of Hungary following an application by Anxiofit Ltd. Question number: EFSA‐Q‐2020‐00032111239745engSDG 3 - Good Health and Well-beingAnxiofit-1Echinacea angustifoliaanxietyhealth claimR MedicineRJournal article10.2903/j.efsa.2020.62641810